Susquehanna Fundamental Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,104
| Closed | -$4.46M | – | 753 |
|
|
2025
Q1 | $4.46M | Sell |
63,104
-106,375
| -63% | -$7.52M | 0.06% | 343 |
|
|
2024
Q4 | $11.1M | Buy |
+169,479
| New | +$11.1M | 0.16% | 166 |
|
|
2024
Q2 | $5.63M | Buy |
+68,346
| New | +$5.63M | 0.13% | 206 |
|
|
2023
Q2 | – | Sell |
-21,627
| Closed | -$2.1M | – | 667 |
|
|
2023
Q1 | $2.1M | Sell |
21,627
-18,969
| -47% | -$1.84M | 0.05% | 362 |
|
|
2022
Q4 | $4.2M | Sell |
40,596
-92,748
| -70% | -$9.6M | 0.07% | 332 |
|
|
2022
Q3 | $11.3M | Buy |
+133,344
| New | +$11.3M | 0.19% | 147 |
|
|
2022
Q1 | $2.77M | Buy |
35,910
+3,630
| +11% | +$280K | 0.05% | 465 |
|
|
2021
Q4 | $2.85M | Sell |
32,280
-48,550
| -60% | -$4.29M | 0.07% | 328 |
|
|
2021
Q3 | $6.25M | Buy |
+80,830
| New | +$6.25M | 0.11% | 237 |
|